Piriformis Syndrome; Extracorporeal Shock Wave Therapy and Dry Needling

NCT ID: NCT06530862

Last Updated: 2024-08-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-03

Study Completion Date

2024-08-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being conducted on patients with piriformis syndrome. Patients are divided into two groups by list randomization method: Extracorporeal shock wave therapy (ESWT) group and Dry neddling (DN) group. Both groups of patients agreed to perform basic stretching exercises. The ESWT group received 3 sessions of radial ESWT, 1 session per week. The DN group received 3 sessions of ultrasound-guided needling, 1 session per week. Clinical evaluations of the participants were performed at the beginning of treatment, 1 month, and 3 months after treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Piriformis Syndrome Extracorporeal Shock Wave Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly divided into 2 groups and will be treated with ESWT or Dry needling
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ESWT group

Patients in this group received three sessions of ESWT at an energy density of 4 bars and a frequency of 2,000 shocks/min at 5 Hz for three weeks, each session once a week.

Group Type ACTIVE_COMPARATOR

ESWT+stretching exercises

Intervention Type OTHER

Participants in this group will receive ESWT treatment

Dry needling

The piriformis muscle of the patients in the group will be dry needled with 0.6\*80 mm acupuncture needles under ultrasound guidance for 3 sessions at one week intervals.

Group Type ACTIVE_COMPARATOR

Dry needling+stretching exercises

Intervention Type OTHER

Participants in this group will receive Dry needling treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESWT+stretching exercises

Participants in this group will receive ESWT treatment

Intervention Type OTHER

Dry needling+stretching exercises

Participants in this group will receive Dry needling treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>18 years
* Complaint for more than 3 months

Exclusion Criteria

* disc pathologies according to radiological imaging
* hip joint and soft tissue pathologies
* recent history of trauma, history of surgery in the lumbar and hip region
* history of rheumatologic disease
* history of polyneuropathy
* history of sciatic nerve injury
* history of malignancy
* opioid analgesia or corticosteroid intervention for pain in the last month
* patients receive another treatment during the study
* Having a contraindication for DN treatment or ESWT treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Burak Tayyip Dede

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Burak Tayyip Dede

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22/12/2023; 2011-KAEK-50;347

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Blind Needling Accuracy in Lumbar Muscles
NCT07074249 NOT_YET_RECRUITING NA